Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community

NCT05087381 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Treatment Efficacy

Interventions

DRUG: FluvoxaMINE Maleate 50 MG
COMBINATION_PRODUCT: Fluvoxamine, Bromhexine
COMBINATION_PRODUCT: Fluvoxamine, Cyproheptadine
DRUG: Niclosamide Pill
COMBINATION_PRODUCT: Niclosamide, Bromhexine

Sponsor

Chulalongkorn University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]